- Home
- XTNT vs GLV Comparison
XTNT vs GLV Comparison
Compare XTNT & GLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XTNT
- GLV
- Stock Information
- Founded
- XTNT N/A
- GLV 2004
- Country
- XTNT United States
- GLV United States
- Employees
- XTNT N/A
- GLV N/A
- Industry
- XTNT Biotechnology: Biological Products (No Diagnostic Substances)
- GLV Finance/Investors Services
- Sector
- XTNT Health Care
- GLV Finance
- Exchange
- XTNT Nasdaq
- GLV Nasdaq
- Market Cap
- XTNT 69.3M
- GLV 72.1M
- IPO Year
- XTNT N/A
- GLV N/A
- Fundamental
- Price
- XTNT $0.59
- GLV $5.56
- Analyst Decision
- XTNT Strong Buy
- GLV
- Analyst Count
- XTNT 1
- GLV 0
- Target Price
- XTNT $3.00
- GLV N/A
- AVG Volume (30 Days)
- XTNT 83.6K
- GLV 54.2K
- Earning Date
- XTNT 11-12-2024
- GLV 01-01-0001
- Dividend Yield
- XTNT N/A
- GLV 12.44%
- EPS Growth
- XTNT N/A
- GLV N/A
- EPS
- XTNT N/A
- GLV N/A
- Revenue
- XTNT $113,862,000.00
- GLV N/A
- Revenue This Year
- XTNT $31.27
- GLV N/A
- Revenue Next Year
- XTNT $13.07
- GLV N/A
- P/E Ratio
- XTNT N/A
- GLV N/A
- Revenue Growth
- XTNT 45.11
- GLV N/A
- 52 Week Low
- XTNT $0.33
- GLV $4.70
- 52 Week High
- XTNT $1.30
- GLV $6.06
- Technical
- Relative Strength Index (RSI)
- XTNT 73.52
- GLV 54.42
- Support Level
- XTNT $0.49
- GLV $5.35
- Resistance Level
- XTNT $0.55
- GLV $5.48
- Average True Range (ATR)
- XTNT 0.07
- GLV 0.08
- MACD
- XTNT 0.01
- GLV 0.03
- Stochastic Oscillator
- XTNT 95.48
- GLV 89.29
About XTNT Xtant Medical Holdings Inc.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the US.
About GLV Clough Global Dividend and Income Fund of beneficial interest
Clough Global Dividend and Income Fund is a closed-ended investment management company. The fund's investment objective is to provide a high level of total return. It invests in equity and debt securities in both U.S. and non-U.S. markets of companies of any market capitalization.